Insider Trading & Ownership - Webster Stephen W

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Webster Stephen W
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2022-08-02
Sale		2022-08-04
6:20 pm		Nabriva Therapeutics plcNBRVWebster Stephen W
Director		7,826$0.19$1,48711,447
(Direct)		View
2021-08-02
Sale		2021-08-04
9:08 pm		Nabriva Therapeutics plcNBRVWebster Stephen W
Director		777$1.2$93219,273
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2023-06-22
Option Award		2023-06-23
4:30 pm		N/A
2033-06-21		NextCure Inc.NXTCWebster Stephen W
Director		14,250$014,250
(Direct)		View
2023-06-08
Option Award		2023-06-12
5:51 pm		N/A
2033-06-07		Cullinan Oncology Inc.CGEMWebster Stephen W
Director		18,450$018,450
(Direct)		View
2023-06-01
Disposition		2023-06-01
4:25 pm		N/A
N/A		TCR2 THERAPEUTICS INC.TCRRWebster Stephen W
Director		51,482$00
(Direct)		View
2022-12-15
Option Award		2022-12-19
5:06 pm		N/A
2032-12-14		TCR2 THERAPEUTICS INC.TCRRWebster Stephen W
Director		16,800$016,800
(Direct)		View
2022-06-23
Option Award		2022-06-24
5:28 pm		N/A
2032-06-22		NextCure Inc.NXTCWebster Stephen W
Director		14,250$014,250
(Direct)		View
2022-06-22
Option Award		2022-06-23
6:18 pm		N/A
2032-06-21		Cullinan Oncology Inc.CGEMWebster Stephen W
Director		16,475$016,475
(Direct)		View
2021-09-16
Option Award		2022-03-25
7:33 pm		N/A
2031-09-15		Cullinan Oncology Inc.CGEMWebster Stephen W
Director		7,800$07,800
(Direct)		View
2021-12-09
Option Award		2021-12-10
4:36 pm		N/A
2031-12-08		TCR2 THERAPEUTICS INC.TCRRWebster Stephen W
Director		12,100$012,100
(Direct)		View
2021-07-28
Option Award		2021-07-30
8:19 pm		N/A
2031-07-27		Nabriva Therapeutics plcNBRVWebster Stephen W
Director		52,500$055,050
(Direct)		View
2021-06-24
Option Award		2021-06-28
6:10 pm		N/A
2031-06-23		NextCure Inc.NXTCWebster Stephen W
Director		14,250$014,250
(Direct)		View

Ownership		2021-01-07
8:40 pm		N/A
2030-10-28		Cullinan Management Inc.CGEMWebster Stephen W
Director		0$025,289
(Direct)		View
2020-12-10
Option Award		2020-12-11
06:22 am		N/A
2030-12-09		TCR2 THERAPEUTICS INC.TCRRWebster Stephen W
Director		12,100$012,100
(Direct)		View
2020-07-29
Option Award		2020-07-31
4:55 pm		N/A
2030-07-28		Nabriva Therapeutics plcNBRVWebster Stephen W
Director		52,500$060,500
(Direct)		View
2020-06-11
Option Award		2020-06-15
5:46 pm		N/A
2030-06-10		NextCure Inc.NXTCWebster Stephen W
Director		14,250$014,250
(Direct)		View
2020-04-30
Option Award		2020-05-04
5:11 pm		N/A
2030-04-29		TCR2 THERAPEUTICS INC.TCRRWebster Stephen W
Director		10,482$010,482
(Direct)		View
2020-01-02
Option Award		2020-01-03
8:01 pm		2021-01-02
2030-01-02		Viking Therapeutics Inc.VKTXWebster Stephen W
Director		22,000$022,000
(Direct)		View
2019-12-17
Disposition		2019-12-17
4:53 pm		N/A
2029-01-15		Spark Therapeutics Inc.ONCEWebster Stephen W
CHIEF FINANCIAL OFFICER		328,515$00
(Direct)		View
2019-12-17
Equity Swap		2019-12-17
4:53 pm		N/A
N/A		Spark Therapeutics Inc.ONCEWebster Stephen W
CHIEF FINANCIAL OFFICER		6,102$114.50
(Direct)		View
2019-07-31
Option Award		2019-08-01
4:15 pm		N/A
2029-07-31		Nabriva Therapeutics plcNBRVWebster Stephen W
Director		35,000$035,000
(Direct)		View
2019-06-13
Option Award		2019-06-17
8:20 pm		N/A
2029-06-12		NextCure Inc.NXTCWebster Stephen W
Director		22,000$022,000
(Direct)		View